Federal antimonopolis (Morocco), epilepsy drugs, respiratory system diseases and ulcerative colitis began to control the cost of 18 drugs. About it Reported In the press service of the department.
The department explained that the service is not only the cost of other drugs from the list of vital and important drugs (GNLP), which are subject to government regulation, but also the cost of other drugs to ensure that pharmaceutical companies are suitable for the antimonyopol legislation.
This year, Morocco has already sent demand to 21 producers with both Russian and foreign companies. Service aims to examine whether the drug prices are exaggerated and exaggerated and exaggerated, especially in the absence of analogs.
If experts put signs of violating the law on the protection of competition, the department will take precautions.
Morocco is already InstalledCompany Kirka-Rur’s antimonopol rules, the monopoly for drug Ko-Dalnev without analogues to violate by setting a high price. Later, the court in Moscow supported the Moroccan decision and ordered the producer to count the price.
On May 12, the Russian Health Protection Federation Duma Duma Committee Vice President of Alexei Kur reported The Russian government is not yet ready to tighten the regulation of drug prices.
According to him, the state is firmly controlling the cost of drugs involved in the vital list. However, even if there is still the potential to reduce the price, the cabinet of the Russian Federation ministers is not yet ready to distribute the state regulation of the cost of all drugs and medical products.
Putin before I got back Pay attention to the complexity of the drug record to the Russian Federation.
What are you thinking?
Source: Gazeta
Ben Stock is a business analyst and writer for “Social Bites”. He offers insightful articles on the latest business news and developments, providing readers with a comprehensive understanding of the business world.